StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Given that the timeframe to settle securities transactions

<< Previous

Bullboard Posts

Next >>

Comment by MoreUpThanDownon Mar 24, 2021 8:12am

162 Views

Post# 32864797

RE:Given that the timeframe to settle securities transactions

Didn't know you had it in you to do a fundamental post, MarketMoney...LOL... You bring up an interesting point... I think my previously posted wild theory may actually be accurate or not so wild; at least a greater possibility for every day that passes now... Glad to see you sticking around until at least the end of Q1 2021!

<< Previous

Bullboard Posts

Next >>

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta